Novo Nordisk Payables and Accrued Expenses (Quarterly) Trends

Novo Nordisk A/S (NVO)

39.07 +0.57 (+1.48%) USD | NYSE | Mar 05, 16:00

38.82 -0.25 (-0.64%) Pre-Market: 07:42

View Payables and Accrued Expenses (Quarterly) for NVO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Ascendis Pharma A/S	--
Evaxion AS	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Viking Therapeutics, Inc.	Upgrade
DBV Technologies SA	Upgrade